In May of this year, Aventis Pharmaceutical, a subsidiary of the pharmaceutical company Sanofi-Aventis, resolved charges that it intentionally misreported drug prices for anti-inflammatory nasal sprays, thereby lowering its rebate payments to Medicaid. In its settlement with the Justice Department, the company committed to pay a $95.5 million fine.
Ver anteriores...
jueves, 26 de noviembre de 2009
The Worst Drug Company Marketing Techniques (VII): AVENTIS
Etiquetas:
Bayer,
BMS,
Lilly,
Marketing,
Merck,
Pfizer,
Precio,
SanofiAventis,
Schering Ploug,
Teva
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario